FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901669507> ?p ?o ?g. }

• W2901669507 endingPage "575" @default.
• W2901669507 startingPage "564" @default.
• W2901669507 abstract "Nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signaling is central to the regulation of several physiological processes, including blood flow and inflammation. Deficient NO signaling is implicated in multiple diseases. sGC stimulators are small molecules that enhance sGC activity, particularly in combination with NO. In a randomized, placebo-controlled phase 1 study, the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple ascending doses of the sGC stimulator praliciguat were assessed in 44 healthy adults. Four cohorts of 11 subjects (8 praliciguat, 3 placebo) received once-daily praliciguat for 14 days before up-titrating for 7 days (treatment sequences: 15/30 mg, 20/40 mg, 30/40 mg, and weight-based). All doses were tolerated. No serious or severe adverse events (AEs) were reported. The most common AEs in praliciguat recipients were headache and symptoms consistent with blood pressure (BP) lowering/vasodilation. There were no laboratory, vital sign, electrocardiographic, or platelet function findings indicative of a safety concern. Pharmacokinetics were dose proportional, with an effective half-life of 24–37 hours, supporting once-daily dosing. Praliciguat produced dose-related increases in plasma cGMP consistent with stimulation of sGC. Repeated once-daily dosing showed sustained decreases in BP. Results support evaluation of praliciguat for the treatment of conditions associated with deficient NO signaling." @default.
• W2901669507 created "2018-11-29" @default.
• W2901669507 creator A5001446657 @default.
• W2901669507 creator A5026251413 @default.
• W2901669507 creator A5027298358 @default.
• W2901669507 creator A5041212945 @default.
• W2901669507 creator A5045134254 @default.
• W2901669507 creator A5049420240 @default.
• W2901669507 creator A5061522022 @default.
• W2901669507 creator A5081847001 @default.
• W2901669507 creator A5089739039 @default.
• W2901669507 creator A5090363906 @default.
• W2901669507 date "2018-11-13" @default.
• W2901669507 modified "2023-09-29" @default.
• W2901669507 title "A Randomized, Placebo-Controlled, Multiple-Ascending-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Soluble Guanylate Cyclase Stimulator Praliciguat in Healthy Subjects" @default.
• W2901669507 cites W152943885 @default.
• W2901669507 cites W164205712 @default.
• W2901669507 cites W1709986041 @default.
• W2901669507 cites W1851039170 @default.
• W2901669507 cites W1960650662 @default.
• W2901669507 cites W1963970407 @default.
• W2901669507 cites W1997582080 @default.
• W2901669507 cites W2055237834 @default.
• W2901669507 cites W2058874166 @default.
• W2901669507 cites W2065102239 @default.
• W2901669507 cites W2073858857 @default.
• W2901669507 cites W2090159456 @default.
• W2901669507 cites W2090169689 @default.
• W2901669507 cites W2107011819 @default.
• W2901669507 cites W2113732858 @default.
• W2901669507 cites W2116338856 @default.
• W2901669507 cites W2120753380 @default.
• W2901669507 cites W2134781575 @default.
• W2901669507 cites W2137092180 @default.
• W2901669507 cites W2142051176 @default.
• W2901669507 cites W2148797779 @default.
• W2901669507 cites W2160204917 @default.
• W2901669507 cites W2161209656 @default.
• W2901669507 cites W2166981101 @default.
• W2901669507 cites W2313226983 @default.
• W2901669507 cites W2323388331 @default.
• W2901669507 cites W2408756274 @default.
• W2901669507 cites W2414176242 @default.
• W2901669507 cites W2559196229 @default.
• W2901669507 cites W2596803679 @default.
• W2901669507 cites W2761635900 @default.
• W2901669507 cites W2766381996 @default.
• W2901669507 cites W2777236800 @default.
• W2901669507 cites W2797298193 @default.
• W2901669507 cites W2805363220 @default.
• W2901669507 doi "https://doi.org/10.1002/cpdd.627" @default.
• W2901669507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30422390" @default.
• W2901669507 hasPublicationYear "2018" @default.
• W2901669507 type Work @default.
• W2901669507 sameAs 2901669507 @default.
• W2901669507 citedByCount "17" @default.
• W2901669507 countsByYear W29016695072018 @default.
• W2901669507 countsByYear W29016695072019 @default.
• W2901669507 countsByYear W29016695072020 @default.
• W2901669507 countsByYear W29016695072021 @default.
• W2901669507 countsByYear W29016695072022 @default.
• W2901669507 countsByYear W29016695072023 @default.
• W2901669507 crossrefType "journal-article" @default.
• W2901669507 hasAuthorship W2901669507A5001446657 @default.
• W2901669507 hasAuthorship W2901669507A5026251413 @default.
• W2901669507 hasAuthorship W2901669507A5027298358 @default.
• W2901669507 hasAuthorship W2901669507A5041212945 @default.
• W2901669507 hasAuthorship W2901669507A5045134254 @default.
• W2901669507 hasAuthorship W2901669507A5049420240 @default.
• W2901669507 hasAuthorship W2901669507A5061522022 @default.
• W2901669507 hasAuthorship W2901669507A5081847001 @default.
• W2901669507 hasAuthorship W2901669507A5089739039 @default.
• W2901669507 hasAuthorship W2901669507A5090363906 @default.
• W2901669507 hasBestOaLocation W29016695071 @default.
• W2901669507 hasConcept C111113717 @default.
• W2901669507 hasConcept C112705442 @default.
• W2901669507 hasConcept C126322002 @default.
• W2901669507 hasConcept C142724271 @default.
• W2901669507 hasConcept C197934379 @default.
• W2901669507 hasConcept C204787440 @default.
• W2901669507 hasConcept C27081682 @default.
• W2901669507 hasConcept C2777288759 @default.
• W2901669507 hasConcept C2778375690 @default.
• W2901669507 hasConcept C2780994212 @default.
• W2901669507 hasConcept C42219234 @default.
• W2901669507 hasConcept C519581460 @default.
• W2901669507 hasConcept C71924100 @default.
• W2901669507 hasConcept C98274493 @default.
• W2901669507 hasConceptScore W2901669507C111113717 @default.
• W2901669507 hasConceptScore W2901669507C112705442 @default.
• W2901669507 hasConceptScore W2901669507C126322002 @default.
• W2901669507 hasConceptScore W2901669507C142724271 @default.
• W2901669507 hasConceptScore W2901669507C197934379 @default.
• W2901669507 hasConceptScore W2901669507C204787440 @default.
• W2901669507 hasConceptScore W2901669507C27081682 @default.
• W2901669507 hasConceptScore W2901669507C2777288759 @default.
• W2901669507 hasConceptScore W2901669507C2778375690 @default.
• W2901669507 hasConceptScore W2901669507C2780994212 @default.

• next